ANAPC10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.086200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.745600E-01
Normal-vs-Stage2
6.705000E-01
Normal-vs-Stage3
5.408800E-01
Normal-vs-Stage4
7.097000E-01
Stage1-vs-Stage2
8.379600E-01
Stage1-vs-Stage3
5.315600E-01
Stage1-vs-Stage4
5.571600E-01
Stage2-vs-Stage3
6.398200E-01
Stage2-vs-Stage4
4.974600E-01
Stage3-vs-Stage4
3.930600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.774400E-01
Normal-vs-AfricanAmerican
8.331000E-01
Normal-vs-Asian
2.303400E-01
Caucasian-vs-AfricanAmerican
9.021200E-01
Caucasian-vs-Asian
2.562000E-02
AfricanAmerican-vs-Asian
1.296820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.997000E-01
Normal-vs-Female
8.660400E-01
Male-vs-Female
1.648820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.270600E-01
Normal-vs-Age(41-60Yrs)
8.920000E-01
Normal-vs-Age(61-80Yrs)
5.267200E-01
Normal-vs-Age(81-100Yrs)
7.169400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.724600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.735000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.066600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.224100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.669600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.698400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.385400E-01
Normal-vs-Daily Drinker
7.031800E-01
Normal-vs-Weekly Drinker
5.091800E-01
Normal-vs-Occasional Drinker
8.108000E-01
Normal-vs-Social Drinker
8.082600E-01
Non Drinker-vs-Daily Drinker
7.018400E-01
Non Drinker-vs-Weekly Drinker
7.024600E-01
Non Drinker-vs-Occasional Drinker
8.123800E-02
Non Drinker-vs-Social Drinker
5.286800E-01
Daily Drinker-vs-Weekly Drinker
5.328400E-01
Daily Drinker-vs-Occasional Drinker
2.243600E-01
Daily Drinker-vs-Social Drinker
8.015000E-01
Weekly Drinker-vs-Occasional Drinker
9.445600E-02
Weekly Drinker-vs-Social Drinker
4.303600E-01
Occasional Drinker-vs-Social Drinker
3.806200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.105600E-02
Normal-vs-Grade 2
2.707600E-02
Normal-vs-Grade 3
5.173600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.851800E-01
Grade 1-vs-Grade 3
2.780600E-01
Grade 1-vs-Grade 4
7.105600E-02
Grade 2-vs-Grade 3
5.940400E-01
Grade 2-vs-Grade 4
2.707600E-02
Grade 3-vs-Grade 4
5.173600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.063600E-01
Normal-vs-NonDiabetic
6.985200E-01
Diabetic-vs-NonDiabetic
5.591400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.315600E-01
Normal-vs-NoPancreatitis
6.979600E-01
Pancreatitis-vs-NoPancreatitis
9.366400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.278000E-01
Normal-vs-N1
7.025800E-01
N0-vs-N1
5.902000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.487600E-01
Normal-vs-TP53-NonMutant
7.749000E-01
TP53-Mutant-vs-TP53-NonMutant
4.128100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
